Show an ad over header. AMP

CRISPR co-discoverer: How gene editing could help fight future pandemics

The coronavirus pandemic is accelerating the development of CRISPR-based tests for detecting disease — and highlighting how gene-editing tools might one day fight pandemics, one of its discoverers, Jennifer Doudna, tells Axios.

Why it matters: Testing shortages and backlogs underscore a need for improved mass testing for COVID-19. Diagnostic tests based on CRISPR — which Doudna and colleagues identified in 2012, ushering in the"CRISPR revolution" in genome editing —are being developed for dengue, Zika and other diseases, but a global pandemic is a proving ground for these tools that hold promise for speed and lower costs.

Driving the news: Last week, the NIH awarded $250 million for the development of COVID-19 diagnostic tests to a handful of companies, including Mammoth Biosciences, which is working on a CRISPR-based test that CEO Trevor Martin says will deliver 200 tests per hour per machine.

  • Another CRISPR-based test, developed by Sherlock Biosciences and CRISPR pioneer Feng Zhang, received an emergency use authorization (EUA) from the Food and Drug Administration in May — the agency's first for any CRISPR-based technology. (Mammoth has since received an EUA for another CRISPR-based test.)
  • "In a way, the timing of the pandemic coincided with this technology being ready to address this emerging need," says Doudna, a co-founder of Mammoth and a biochemist at UC Berkeley.
  • Of note: UC Berkeley and The Broad Institute of MIT and Harvard, where Zhang is a professor, are in a years-long patent battle over the use of CRISPR in human cells, with potentially billions of dollars from licensing the technology at stake.

The challenge now is "getting it into a format where it can be used easily either in a laboratory or at the point-of-care," like the doctor's office or home, she says.

How it works: Clustered Regularly Interspaced Short Palindromic Repeats, or CRISPR, are sequences of genetic code that bacteria naturally use to find and destroy viruses.

  • Diagnostic tests work by programming CRISPR to search for a particular stretch of RNA or DNA in a virus. If thepathogen is found, enzymes guided by the CRISPR sequence put out a signal.
  • CRISPR can also lead enzymesto a gene that the enzyme then precisely snips or edits, turning it on or off or changing its function.

That editing ability is viewed as having vast potential for treating disease, a nascent use of CRISPR.

  • Earlier this summer, researchers announced that a CRISPR-based therapy appeared to be effective in treating a woman with sickle cell anemia, NPR reported.
  • The approach, in which cells are removed from the body, edited and reinfused via a bone marrow transplant, is expensive. (Gene therapy for a related blood disorder costs about $1.8 million for the treatment alone.)
  • Efficiently delivering CRISPR directly to cells in the body could drive down the cost, says Doudna.

But there's a persistent problem: Getting the sizable CRISPR system through the membranes and to the DNA of the cells that need editing.

  • That's "the bleeding edge" of the field, says Doudna, whose team and others are trying to solve the delivery challenges.
  • Last month, they reported finding a compact form of CRISPR in a virus that infects bacteria. Doudna suspects its small size may make it easier to get it into cells.

And, there are other concerns about off-target editing with currently available enzymes and unknown long-term effects of gene editing directly in the body.

The intrigue: CRISPR could one day be wielded in future pandemics.

  • Some researchers propose it could be used to attack viruses like SARS-CoV-2.
  • Orit might be possible to one day edit immune cells in the body so they are less susceptible to becoming exhausted by a disease, Doudna says.

Yes, but: That would require sophisticated understanding of how a virus changes and the immune system's complex response to it.

  • Some of those questions could be unraveled using machine learning to determine the consequences of perturbing a particular gene in a specific tissue, Doudna says.
  • And if researchers can determine which regions of genetic material in a virus or bacteria don't change over time, CRISPR could be used to program immune cells to recognize those regions and be ready for a type of virus before it shows up, she says, pointing to the use of CRISPR to prime the immune system to attack cancer.

The big picture: Such "genetic vaccination" is a long way off, but it could eliminate having to wait until a virus shows up, make a vaccine to that virus and then vaccinate people, she says.

  • Each year, the influenza vaccine's makeup involves anticipating which strains may be most prevalent by studying the virus' proteins.
  • "I sort of imagine a day we could do that at the genetic level," Doudna says.

Trump says he agreed to TikTok deal "in concept"

President Trump on Saturday said he approved "in concept" a deal whereby TikTok will be allowed to continue operating in the U.S., with Oracle as its "trusted technology partner."

Why it matters: TikTok has nearly 100 million U.S. users, and is still growing fast. Trump has threatened to ban it, due to data privacy concerns related to TikTok's ownership by Chinese tech company

Keep reading... Show less

Trump says he expects to announce a nominee for Supreme Court vacancy "next week"

President Trump said Saturday he expects to announce a nominee for Justice Ruth Bader Ginsburg's vacant Supreme Court seat “next week” and that the person will “most likely” be a woman.

What he's saying: “I think we’ll have a very popular choice whoever that may be," Trump said before departing on Marine One. "We want to respect the process. I think it’s going to go very quickly, actually.”

Go deeper: Trump says Republicans have an obligation to fill Ginsburg's seat

Susan Collins says Senate should postpone Supreme Court vote until after Election Day

Sen. Susan Collins (R-Maine) said in a statement Saturday that she believes the Senate should wait to vote to confirm a Supreme Court nominee to fill Justice Ruth Bader Ginsburg's seat until after the general election.

Why it matters: Collins will be a key senator in how this process plays out. As one of the most centrist Senate Republicans, whether or not the Senate confirms Trump's SCOTUS nominee could hinge on her vote.

Keep reading... Show less

Pinpointing climate change's role in extreme weather

Climate scientists are increasingly able to use computer models to determine how climate change makes some extreme weather more likely.

Why it matters: Climate change's effects are arguably felt most directly through extreme events. Being able to directly attribute the role climate plays in natural catastrophes can help us better prepare for disasters to come, while driving home the need to tackle greenhouse gas emissions.

Keep reading... Show less

Big Tech takes the climate change lead

The tech industry is playing a growing role in fighting climate change, from zero-carbon commitments to investments in startups and pushing for the use of data to encourage energy efficiency.

Why it matters: Big Tech is already dominating our economy, politics and culture. Its leadership in helping to address climate change — and reckon with its role in contributing to it — could have similarly transformative impacts.

Keep reading... Show less

Lindsey Graham says he will vote for Ginsburg's replacement before next election

Sen. Lindsey Graham (R-S.C.) on Saturday said he plans to support a vote on President Trump's nominee to fill the vacancy left by Supreme Court Justice Ruth Bader Ginsburg, who died on Friday, before the election.

Why it matters: Graham in 2016 opposed confirming President Obama's Supreme Court nominee, Merrick Garland, because it was an election year.

Keep reading... Show less

Schumer: "Nothing is off the table next year" if Senate GOP moves to fill Ginsburg's seat

Senate Minority Leader Chuck Schumer told fellow Democrats on a conference call Saturday that "nothing is off the table next year" if Senate Republicans move to fill Justice Ruth Bader Ginsburg's Supreme Court seat in the coming weeks.

What he's saying: “Let me be clear: if Leader McConnell and Senate Republicans move forward with this, then nothing is off the table for next year," Schumer said, according to a source on the call. "Nothing is off the table.”



Get Goodhumans in your inbox

Most Read

More Stories